ADAM9 and neoplasm: In the previous studies, miR-136-3p inhibits cell growth and metastasis by targeting solute carrier family 7 member 5 (SLC7A5) and ADAM metallopeptidase domain 9 (ADAM9) in thyroid cancer [16], suggesting that miR-136-3p might function as a tumor suppressor in cancers including gliomas.